Advanced Health Limited (JSE:AVL) News - Strategic review of Advanced Health ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “Advanced Health”) ISIN Code: ZAE000189049 JSE Code: AVL STRATEGIC REVIEW OF ADVANCED HEALTH Shareholders are advised that the Advanced Health board of directors has appointed an internal sub- committee to conduct a strategic review of the Advanced Health group to assess options available to maximise shareholder value in Advanced Health. This process will involve an assessment of Advanced Health’s strategic options and the alternative strategies available to unlock and enhance value for Advanced Health shareholders. There are no assurances that the board will decide to pursue, nor that any transaction or transactions will result from, this strategic review. Shareholders do not need to take any action in relation to the strategic review. Advanced Health will continue to keep shareholders informed about the progress and outcomes of the strategic review. Pretoria 15 June 2022 Designated Advisor Grindrod Bank Limited Date: 15-06-2022 11:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.